BioCorRx Inc.

$0.40-10.17%($-0.05)
TickerSpark Score
67/100
Solid
40
Valuation
60
Profitability
100
Growth
36
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BICX research report →

52-Week Range19% of range
Low $0.20
Current $0.40
High $1.28

Companywww.biocorrx.com

BioCorRx Inc. , through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.

CEO
Lourdes Felix
IPO
2010
Employees
3
HQ
Anaheim, CA, US

Price Chart

+28.62% · this period
$0.50$0.35$0.20May 20Nov 18May 20

Valuation

Market Cap
$8.35M
P/E
-2.99
P/S
9.52
P/B
-0.89
EV/EBITDA
-5.25
Div Yield
0.00%

Profitability

Gross Margin
83.96%
Op Margin
-552.33%
Net Margin
-391.15%
ROE
28.12%
ROIC
111.61%

Growth & Income

Revenue
$797.24K · 10301.10%
Net Income
$-3,440,146 · 32.63%
EPS
$-0.19 · 61.22%
Op Income
$-4,831,642
FCF YoY
-109.65%

Performance & Tape

52W High
$1.28
52W Low
$0.20
50D MA
$0.38
200D MA
$0.37
Beta
0.14
Avg Volume
1.53K

Get TickerSpark's AI analysis on BICX

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Dec 31, 24Lucido Louis C.other13,158
Dec 31, 24Lucido Louis C.other43,860
Nov 29, 24Lucido Louis C.other55,494
Oct 31, 24Lucido Louis C.other55,556
Oct 14, 24Lucido Louis C.other1,105,218
Sep 30, 24Lucido Louis C.other15,625
Sep 30, 24Lucido Louis C.other52,085
Aug 30, 24Lucido Louis C.other55,559
Jul 31, 24Lucido Louis C.other32,092
Apr 24, 24Lucido Louis C.other460,477

Our BICX Coverage

We haven't published any research on BICX yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BICX Report →

Similar Companies